Acceptability and experiences of real-time continuous glucose monitoring in adults with type 2 diabetes using insulin: a qualitative study
Authors:
- Oscar T. Sergel-StringerOSOscar T. Sergel-Stringer
- Benjamin J. WheelerBWBenjamin J. Wheeler
- Sara E. StylesSSSara E. Styles
- Alisa BoucseinABAlisa Boucsein
- Claire S. LeverCLClaire S. Lever
- Ryan G. PaulRPRyan G. Paul
- Rachael SampsonRSRachael Sampson
- Antony WatsonAWAntony Watson
- Martin I. de BockMBMartin I. de Bock
Open Access
- 5 March 2024
- journal article
- research article
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 23 (1) , 1163-1171
Abstract
Aims: To explore the lived experiences of initiating real-time continuous glucose monitoring (rt-CGM) use in individuals with type 2 diabetes using insulin. Methods: Twelve semi-structured interviews were conducted amongst individuals with type 2 diabetes taking insulin who were enrolled in the 2GO-CGM randomised controlled trial and had completed 3 months of rtCGM. Interviews were transcribed verbatim and analysed to identify common themes regarding their experiences. Results: The interviews revealed three key themes: i) rtCGM as a facilitator of improved health behaviours; ii) the acceptability of rtCGM systems compared to capillary blood glucose testing; and iii) barriers to the continual usage of rtCGM technology – including: connection difficulties, longevity of the sensors, and local cutaneous reactions to the sensor adhesive. Conclusion: Adults on insulin with type 2 diabetes find rtCGM systems widely acceptable, and easier to engage with than traditional self-monitoring of capillary blood glucose.Keywords
Funding Information
- Dexcom
- University of Otago
This publication has 27 references indexed in Scilit:
- Study protocol: glycaemic outcomes in people with type 2 diabetes initiating continuous glucose monitoring: the 2GO-CGM studyJournal of Diabetes & Metabolic Disorders, 2023
- Perceived impact of continuous glucose monitor use on quality of life and self-care for patients with type 2 diabetesDiabetes Epidemiology and Management, 2022
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045Diabetes Research and Clinical Practice, 2022
- Personal Continuous Glucose Monitoring Use Among Adults with Type 2 Diabetes: Clinical Efficacy and Economic ImpactsCurrent Diabetes Reports, 2021
- Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated DiabetesJAMA, 2021
- Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal InsulinJAMA, 2021
- Change in Hemoglobin A1c and Quality of Life with Real-Time Continuous Glucose Monitoring Use by People with Insulin-Treated Diabetes in the Landmark StudyDiabetes Technology & Therapeutics, 2021
- Cost, Hassle, and On-Body Experience: Barriers to Diabetes Device Use in Adolescents and Potential Intervention TargetsDiabetes Technology & Therapeutics, 2020
- Preserving Skin Integrity with Chronic Device Use in DiabetesDiabetes Technology & Therapeutics, 2018
- Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: A meta-analysisDiabetes Research and Clinical Practice, 2018